Focusing on both the patient's perspective and the neurosurgeon's concerns, Intracranial Arteriovenous Malformations: Essentials for Patients and Practitioners, edited by leading experts Drs. Philip E. Stieg, Alexander A. Khalessi, and Michael L. J. Apuzzo, starts with an up-to-date approach to the matter of doctor-patient communication and moves on to the highly technical details of AVM treatment options. The first section covers communication with patients (who may well want to read it themselves); the second section is directed to neurosurgeons and other specialists caring for patients with intracranial AVMs, including those in emergency medicine, obstetrics, anesthesia, and intensive care. It offers a highly sophisticated but readable approach to the contemporary treatment of these challenging lesions. Provides expert guidance on diagnosis, histopathology, natural history, anatomy, imaging, and treatment options and their risks and benefits-all with the goal of helping patients make informed decisions about the optimal management choices for their own individual cases.  Facilitates articulate, data-driven discussion and regarding the clinical diagnosis and surgical procedures involved in treating AVMs.  Addresses specific, difficult issues that arise during the treatment of AVMs, offering real-world advice to neurosurgeons and other care providers.  Includes key pearls in every chapter, as well as stunning anatomical illustrations throughout.  An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. 

This volume is part of a two-volume work designed to present a focused discussion of the major investigational areas which are representative of a range of activity and the "pieces of the puzzle" that are currently in place to make significant near term advances in the management of cerebral glioma. This first volume presents the rapidly expanding, multi-disciplinary body of knowledge about the development, molecular biology, molecular genetics, and pathology of human cerebral gliomas. Volume II synthesizes the considerable amount of information on the classic and evolving tools in the clinical treatment of gliomas, and further presents practical guidelines for contemporary clinical management within the framework of medicine's current, collective knowledge. Physicians who demonstrate their comprehension of the material presented in "Benign Cerebral Glioma, Volumes I & II" by completing and self-scoring ten multiple choice questions corresponding to each chapter may earn 30 credit hours (15 hours per volume) in Category I of the Physician's Recognition Award of the AMA. The Category I credit hours are awarded upon the return of a brief evaluation form and a modest processing fee.

The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.